Dental Membrane and Bone Graft Substitute Market By Product Type (Synthetic Bone Graft, Xenograft, Autograft, Allograft, and Demineralized Allograft), By Material (Hydrogel, Collagen, Human Cells Source, and Other Species (Hydroxyapatite, Tricalcium Phosphate, and Polytetrafluoroethylene), By Application (Ridge Augmentation, Socket Preservation, Periodontal Defect Regeneration, Implant Bone Regeneration, Sinus Lift, and Others), By End-user (Hospitals, Ambulatory Surgical Centers, and Dental Clinics), and By Region - Trends, Analysis, and Forecast till 2029

Membrane and bone graft substitute Market accounted for USD 0.74 Billion in 2019 and is estimated to be USD 1.74 Billion by 2029 and is anticipated to register a CAGR of 9.0%.

Dental membranes and bone graft substitutes are used to address oral health issues. The growing incidence of periodontal diseases is projected to surge the demand for Dental membranes and bone graft substitutes. A dental membrane averts the gum from developing into the bone cavity. Bone graft substitutes are used in bone grafting. Bone grafting is a process to replace the missing bone with an artificial, synthetic, or natural substitute. Different types of dental membranes are mainly used along with bone graft implants. 

According to the FDI World Dental Federation, oral disease affects 3.9 billion people globally, with untreated tooth decay (dental caries) impacting almost half of the world’s population (44%).  Worldwide, between 60–90% of schoolchildren and approximately 100% of adults have tooth decay, often leading to discomfort and pain. The severe periodontal disease which may result in tooth loss is found in 15–20% of middle-aged (35–44 years) adults. Dental cases are the most common chronic disease in the world, affecting public health problems mainly due to exposure to sugar and other risks. Thus, increasing the incidence of oral health disorders is driving the growth of the target market globally.

The increasing collaboration and acquisition activities

Several key players are undertaking growth strategies such as mergers and acquisitions to expand their product portfolio in newer geographies, which is projected to boost the growth of the market in the upcoming years. For instance, For instance, Danaher Corporation established its strong presence in the dental membrane and bone graft substitutes market through the acquisition of 100% interest in Implant Direct in 2017 and Nobel Biocare Services AG in 2014.

Conversely, the high cost of bone graft procedures and stringent government regulations are anticipated to limit the growth of the dental membranes and bone graft substitutes market over the forecast period.

The dental membrane and bone graft substitute market is segmented based on the product type, material, application, end-user, and region.

Depending upon the product type, the business is categorized into the synthetic bone graft, xenograft, autograft, allograft, and demineralized allograft. In terms of material, the worldwide industry is categorized into hydrogel, collagen, human cell source, and other species (hydroxyapatite, tricalcium phosphate, and polytetrafluoroethylene. Based on the application, the target market is segmented into ridge augmentation, socket preservation, periodontal defect regeneration, implant bone regeneration, sinus lift, and others. Based on the end-user, the target market is segmented into hospitals, ambulatory surgical centers, and dental clinics.

Regional Insights:

Regionally, the overall industry is divided into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. Europe dominates the dental membrane and bone graft substitute market in terms of revenue as compared to other regions. The increasing number of surgeries performed and growing awareness about periodontology in the region is propelling the growth of the target market. North America accounts for the second-highest revenue share to the target market, followed by markets in the Asia Pacific, Middle East & Africa, and Latin America. The Asia Pacific is expected to witness relatively faster growth in terms of revenue in the upcoming years, owing to the increasing dentist population in the region.

Dental Membrane and Bone Graft Substitute Market Report Scope:

Segments Covered in the Report:

This report forecasts revenue growth at , regional, and country levels and provides an analysis of the latest industry trends and opportunities in each of the sub-segments from 2019 to 2029.  For the purpose of this study, has segmented the dental membrane and bone graft substitute market report based on product type, material, application, end-user, and region.

Dental Membrane and Bone Graft Substitute Market, By Product Type:

• Synthetic Bone Graft
• Xenograft
• Autograft
• Allograft
• Demineralized Allograft

Dental Membrane and Bone Graft Substitute Market, By Material:

• Hydrogel
• Collagen
• Human Cells Source
• Other Species

• Hydroxyapatite
• Tricalcium Phosphate
• Polytetrafluoroethylene

 Dental Membrane and Bone Graft Substitute Market, By Application:

• Ridge Augmentation
• Socket Preservation
• Periodontal Defect Regeneration
• Implant Bone Regeneration
• Sinus Lift
• Others

Dental Membrane and Bone Graft Substitute Market, By End-user:

• Hospitals
• Ambulatory Surgical Centers
• Dental Clinics

Dental Membrane and Bone Graft Substitute Market, By Region:

• North America
  • Middle East & Africa
    • • GCC
      • Israel
      • South Africa
      • Rest of Middle East & Africa
  • Latin America
    • • Brazil
      • Mexico
      • Rest of Latin America
  • Asia Pacific
    • • China
      • India
      • Japan
      • South Korea
      • Rest of Asia Pacific
  • Europe
    • • Germany
      • UK
      • France
      • Russia
      • Italy
      • Rest of Europe
  • U.S.
  • Canada

The key players operating in the dental membrane and bone graft substitute market include Zimmer Biomet Holdings, Inc., ACE Surgical Supply Company, Inc., Geistlich Pharma North America Inc., LifeNet Health, RTI Surgical Holdings, Inc., BioHorizons, Inc., Dentsply Sirona Inc., Institut Straumann AG, and Citagenix, Inc. For instance, in October 2019, LifeNet Health, a leader in regenerative medicine opened a technologically advanced logistics and distribution center in Indianapolis. This aims to add unmatched reliability and on-demand, just-in-time delivery capabilities to patients and hospitals around the world.

• Zimmer Biomet Holdings, Inc.
• Geistlich Pharma North America Inc.
• LifeNet Health
• RTI Surgical Holdings, Inc.
• BioHorizons, Inc.
• Dentsply Sirona Inc.
• Institut Straumann AG
• Citagenix, Inc.